Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Somatodendritic dopamine … - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod.

Artikel i vetenskaplig tidskrift
Författare Filip Bergquist
Haydeh Niazi Shahabi
Hans Nissbrandt
Publicerad i Brain research
Volym 973
Nummer/häfte 1
Sidor 81-91
ISSN 0006-8993
Publiceringsår 2003
Publicerad vid Institutionen för fysiologi och farmakologi, Avdelningen för farmakologi
Sidor 81-91
Språk en
Länkar www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Animals, Dendrites, drug effects, metabolism, secretion, Dopamine, metabolism, secretion, Dopamine Antagonists, pharmacology, Dose-Response Relationship, Drug, Female, Microdialysis, methods, Psychomotor Performance, drug effects, physiology, Rats, Rats, Sprague-Dawley, Serotonin, metabolism, secretion, Substantia Nigra, drug effects, metabolism, secretion
Ämneskategorier Fysiologi

Sammanfattning

The physiological role of somatodendritic dopamine release in the rat substantia nigra was evaluated with a combination of dual probe microdialysis and simultaneous motor performance tests on an accelerating rod. Three main findings support a modulating influence of somatodendritic dopamine release on motor coordination. (1) The rod performance tests were associated with an increase in extracellular dopamine but not 5-hydroxytryptamine concentrations in substantia nigra and with increases in both dopamine and 5-hydroxytryptamine concentrations in the striatum. (2) Nigral application of dopamine antagonists without intrinsic activity resulted in changed performances on the accelerating rod. The response to nigral perfusion with low concentrations (0.1, 1.0 microM) of the D(2)/D(3)-antagonist raclopride consisted of an impairment in rod performance to 63% of the pre-perfusion performance. Higher concentrations (10, 100 microM), however, were not associated with impaired rod performance, but with increased striatal dopamine concentrations. Perfusion of the substantia nigra with 1, 10 and 100 microM of the D(1)/D(5)-antagonist SCH 23390 dose-dependently impaired rod performance. SCH 23390 consistently increased dopamine and 5-hydroxytryptamine concentrations in substantia nigra but did not change the dialysate in the striatum. (3) In unilaterally 6-hydroxydopamine-lesioned rats, a dose-dependent improvement in rod performance was observed during perfusion of the substantia nigra with the non-selective dopamine agonist apomorphine.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?